Background and objective. Botulinum toxin is effective in the treatment of
hyperhidrosis and the demand for therapy is increasing. Simultaneously we h
ave observed an increase in patients with body dysmorphic disorders who a l
so wa nt botulinum toxin therapy. This botulinophilie is a new variant of v
enenophilie. We investigated the prevalence of this new diagnosis in our pa
tient population.
Patients/Methods. In the first quarter of 2000 we studied the biopsychosoci
al features of 13 patients with hyperhidrosis.
Results. In 23.1% of our cases we were able to confirm a botulinophilie wit
h body dysmorphic disorder and a normal Minor sweat test.
Conclusions. Botulinophilie is not an indication for botulinum toxin therap
y but for psychotherapy.